Company Name: |
TargetMol Chemicals Inc.
|
Tel: |
4008200310 |
Email: |
marketing@tsbiochem.com |
Products Intro: |
Product Name:ZL0590;non-KAc binding site,ZL0590,ZL-0590,BRD4 BD1,Inhibitor,acute airway inflammation,inhibit,Epigenetic Reader Domain,ZL 0590 CAS:2230496-99-6 Purity:99.95% Package:1 mg;1 mL;10 mg;100 mg;200 mg;25 mg;5 mg;50 mg
|
Company Name: |
RD International Technology Co., Limited
|
Tel: |
18024082417 |
Email: |
market@ubiochem.com |
Products Intro: |
Product Name:ZL0590 CAS:2230496-99-6 Purity:5mg;10mg;50mg;100mg;250mg;500mg;1g Package:5mg;10mg;50mg;100mg;250mg;500mg;1g
|
|
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Basic information |
Product Name: | Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- | Synonyms: | Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]-;ZL0590;non-KAc binding site,ZL0590,ZL-0590,BRD4 BD1,Inhibitor,acute airway inflammation,inhibit,Epigenetic Reader Domain,ZL 0590 | CAS: | 2230496-99-6 | MF: | C23H27F3N4O4S | MW: | 512.55 | EINECS: | | Product Categories: | | Mol File: | 2230496-99-6.mol | ![Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Structure](CAS/20210305/GIF/2230496-99-6.gif) |
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Chemical Properties |
density | 1.411±0.06 g/cm3(Predicted) | storage temp. | Store at -20°C | form | Solid | pka | 13.38±0.70(Predicted) | color | White to off-white |
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Usage And Synthesis |
Biological Activity | ZL0590 is a potent, orally active BRD4 BD1-selective inhibitor with an IC50 of 90 nM for human BRD4 BD1. ZL0590 exhibits significant anti-inflammatory activities[1]. | References | [1]. Liu Z, et al. Discovery, X-ray Crystallography, and Anti-inflammatory Activity of Bromodomain-containing Protein 4 (BRD4) BD1 Inhibitors Targeting a Distinct New Binding Site. J Med Chem. 2022;65(3):2388-2408. |
| Urea, N-[4-[[(2S)-2-(4-morpholinylmethyl)-1-pyrrolidinyl]sulfonyl]phenyl]-N'-[4-(trifluoromethyl)phenyl]- Preparation Products And Raw materials |
|